Median Technologies to Showcase iCRO’s Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026

About this update from Median Technologies

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1240,"height":461,"url":"https://media.zenfs.com/en/business-wire.com/3bea596e26fb692a2f0bb296c8936f4e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DjYS.ZFkn5l0udql01YBaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1Nw--/https://media.zenfs.com/en/business-wire.com/3bea596e26fb692a2f0bb296c8936f4e","width":960,"height":357},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/R42hePyq_QZfTwJrj_mWMQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTIzOA--/https://media.zenfs.com/en/business-wire.com/3bea596e26fb692a2f0bb296c8936f4e","width":640,"height":238},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/RWCSkDMQRJ9kprZWVRRDiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTI-/https://media.zenfs.com/en/business-wire.com/3bea596e26fb692a2f0bb296c8936f4e","width":1200,"height":446}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Median is a leading provider of imaging services to the world’s top oncology pharma companies","length":93,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Median will host two presentation sessions to introduce its new solutions for radiopharmaceutical image processing and cachexia assessment for oncology research at booth #36102","length":176,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":269,"olType":false},{"type":"text","content":"SOPHIA ANTIPOLIS, France, May 26, 2026--(BUSINESS WIRE)--Regulatory News:","length":73,"tagName":"p"},{"type":"text","content":"Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will be participating in the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 29 to June 2, McCormick Place, Chicago, IL, USA.","length":541,"tagName":"p"},{"type":"text","content":"Median’s team will be hosting interested parties at booth #36102, South Building, Hall A, McCormick Place, from May 30 to June 1 (exhibit dates), from 9:00 am to 5:00 pm CT, where i...

More updates from Median Technologies